Current Urology Reports ( IF 2.5 ) Pub Date : 2023-06-01 , DOI: 10.1007/s11934-023-01167-4 Mriganka Mani Sinha 1 , Vineet Gauhar 2 , Lazaros Tzelves 3 , Tzevat Tefik 4 , Rifat Burak Ergul 4 , Patrick Juliebø-Jones 5 , Bhaskar K Somani 6
Purpose of Review
Robotic surgery in urology has already been widely employed in robotic-assisted laparoscopic surgery for minimally invasive procedures (MIS). We wanted to analyse rapidly developing robotic ureteroscopy (RoboURS) for the treatment of renal stone disease.
Recent Findings
A comprehensive literature review was performed for technical aspects and clinical outcomes of RoboURS. RoboURS has made significant breakthroughs with each model proving that this technology improves ergonomics and supports surgeon and instrument longevity while minimising musculoskeletal issues in retrograde intra-renal surgery (RIRS). Further randomised controlled trials are required to compare the efficacy of RoboURS vs manual flexible ureteroscopy (FURS). The cost-effectiveness will also need to be assessed prior to widespread acceptance into urological infrastructure and mainstream practice.
Summary
RoboURS continues to evolve despite the limitations of infrastructure and cost-effectiveness. It holds the promise of a better future for surgeon longevity, reduced peri-operative morbidity and better workplace environment.
中文翻译:
机器人输尿管镜的技术方面和临床结果:它准备好迎接黄金时段了吗?
审查目的
泌尿外科机器人手术已广泛应用于机器人辅助腹腔镜微创手术(MIS)。我们想要分析快速发展的机器人输尿管镜检查 (RoboURS) 用于治疗肾结石疾病的方法。
最近的发现
对 RoboOURS 的技术方面和临床结果进行了全面的文献综述。 RoboURS 的每个模型都取得了重大突破,证明该技术改善了人体工程学并支持外科医生和器械的使用寿命,同时最大限度地减少逆行肾内手术 (RIRS) 中的肌肉骨骼问题。需要进一步的随机对照试验来比较 RoboURS 与手动输尿管软镜 (FURS) 的疗效。在被泌尿外科基础设施和主流实践广泛接受之前,还需要评估成本效益。
概括
尽管存在基础设施和成本效益的限制,RoboURS 仍在不断发展。它有望为外科医生延长寿命、降低围手术期发病率和改善工作环境创造更美好的未来。